Tag: Cancer: Prostate
Relugolix Beneficial for Prostate Cancer Patients Undergoing Radiotherapy
Short- or longer-term relugolix achieves sustained castration in patients with localized and advanced prostate cancer
Disparities in Transgender Prostate Screening Uptake Driven by Clinicians
Clinician-led recommendations for and discussions of PSA screening explained differences between cisgender and transgender screening rates
Plant-Based Food Intake Linked to Better QoL in Prostate Cancer
Higher plant-based diet index linked to better scores for sexual function, urinary irritation/obstruction, urinary incontinence, hormonal/vitality
Change in Cardiorespiratory Fitness Linked to Prostate Cancer Incidence
Change in CRF inversely linked to prostate cancer incidence, but no association seen for prostate cancer mortality
Treatment Adverse Events Vary With Favorable, Unfavorable Prognosis in Prostate Cancer
Radical prostatectomy linked to worse urinary incontinence but not worse sexual function for men with favorable, unfavorable prognosis
Digital Rectal Exam Has Low Diagnostic Value for Prostate Cancer
Low diagnostic value seen as independent test and supplementary measure to PSA for detection of prostate cancer
Most Men Choose Active Surveillance for Low-Risk Prostate Cancer
Recommendation by urologist was strongest determinant for AS uptake; shared treatment decision also linked to AS
Receipt of Novel Hormonal Therapy for Advanced Prostate Cancer Varies With Race
Black patients had significantly lower use of NHT than White patients, which persisted at five years
MRI Measure May ID Men at Risk for Postradiation Genitourinary Toxicity
Longer prostatic urethral length independently tied to higher risk for developing late genitourinary toxicity
Black Men More Likely Than Whites to Have Prostate Cancer at Any Given PSA...
Black men more likely than White men to receive a prostate cancer diagnosis on their first prostate biopsy